4//SEC Filing
Prokupets Elena 4
Accession 0001209191-21-058111
CIK 0001662579other
Filed
Sep 28, 8:00 PM ET
Accepted
Sep 29, 6:33 PM ET
Size
7.6 KB
Accession
0001209191-21-058111
Insider Transaction Report
Form 4
Prokupets Elena
Director
Transactions
- Sale
Common Stock
2021-09-27$50.04/sh−1,311$65,604→ 503,126 total(indirect: By ERP Business Holdings, LP) - Sale
Common Stock
2021-09-27$50.04/sh−539$26,969→ 31,681 total(indirect: By Spouse)
Footnotes (5)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F5]Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001824823
Filing Metadata
- Form type
- 4
- Filed
- Sep 28, 8:00 PM ET
- Accepted
- Sep 29, 6:33 PM ET
- Size
- 7.6 KB